A detailed history of Eagle Bay Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 9,189 shares of ABT stock, worth $1.08 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
9,189
Previous 9,124 0.71%
Holding current value
$1.08 Million
Previous $948,000 10.44%
% of portfolio
0.61%
Previous 0.58%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$100.07 - $118.13 $6,504 - $7,678
65 Added 0.71%
9,189 $1.05 Million
Q2 2024

Jul 26, 2024

BUY
$100.73 - $112.44 $74,842 - $83,542
743 Added 8.87%
9,124 $948,000
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $18,946 - $20,926
173 Added 2.11%
8,381 $952,000
Q4 2023

Feb 08, 2024

SELL
$90.19 - $110.4 $4,599 - $5,630
-51 Reduced 0.62%
8,208 $903,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $2,197 - $2,636
23 Added 0.28%
8,259 $799,000
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $1,814 - $2,021
18 Added 0.22%
8,236 $897,000
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $8,039 - $9,462
-83 Reduced 1.0%
8,218 $832,000
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $135,555 - $159,027
-1,426 Reduced 14.66%
8,301 $0
Q3 2022

Nov 22, 2022

SELL
$96.76 - $112.03 $4,644 - $5,377
-48 Reduced 0.49%
9,727 $941,000
Q2 2022

Aug 19, 2022

BUY
$102.07 - $123.37 $16,229 - $19,615
159 Added 1.65%
9,775 $1.06 Billion
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $58,378 - $71,188
512 Added 5.62%
9,616 $1.14 Million
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $252,317 - $308,948
-2,184 Reduced 19.35%
9,104 $1.28 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $160,874 - $177,973
1,379 Added 13.92%
11,288 $1.33 Million
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $1.05 Million - $1.23 Million
9,909 New
9,909 $1.16 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.